Literature DB >> 11460877

17Beta-estradiol stimulates mineralized bone nodule formation when added intermittently to SaOS-2 cells.

L G Rao1, L J Liu, T M Murray, E McDermott.   

Abstract

It is now well established that estrogen inhibits bone resorption. However, its effect on bone formation remains controversial. We studied the effect of 17beta-estradiol (E2) on mineralized bone nodule formation in long-term cultures of osteosarcoma SaOS-2 cells. We showed that SaOS-2 cells formed mineralized nodules which under electron microscopy revealed a bone structure with active osteoblasts, entrapped osteocytes, extracellular collagen fibrils and hydroxyapatite deposits, making this system a valid model to study bone formation in vitro. Intermittent addition of E2 for 6 hours during a 48-hour cycle of changes of medium, starting from day 3, resulted in a dose-dependent stimulation of mineralized bone nodule number and area, as well as alkaline phosphatase activity. In conclusion, we report for the first time a stimulatory effect of E2 on mineralized bone nodule formation in human osteoblasts in culture.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11460877     DOI: 10.1515/dmdi.2001.18.2.149

Source DB:  PubMed          Journal:  Drug Metabol Drug Interact        ISSN: 0792-5077


  2 in total

1.  Effect of raloxifene and its interaction with human PTH on bone formation.

Authors:  Y Lin; L J F Liu; T Murray; J Sodek; L Rao
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

2.  Estrogen/estrogen receptor alpha signaling in mouse posterofrontal cranial suture fusion.

Authors:  Aaron W James; Alexander A Theologis; Samantha A Brugmann; Yue Xu; Antoine L Carre; Philipp Leucht; Katherine Hamilton; Kenneth S Korach; Michael T Longaker
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.